Back to STATE STREET CORP STATE STREET CORP

BDTXBDTX
Showing 8 of 11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in BLACK DIAMOND THERAPEUTICS I

STATE STREET CORP holds 525,013 shares of BDTX (BLACK DIAMOND THERAPEUTICS I), worth $971,274 as of 2026-Q2. The position was increased (+145.9% shares).

Current Value

$971,274

Current Shares

525,013

Total Value Change

-$2.5M

Total Shares Change

-284,183

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
525,013
+145.9%
$971,2740.0%$1.85
27
2026-Q1
Unchanged
213,513
0.0%
$454,7830.0%$2.30
0
2025-Q4
Unchanged
213,513
0.0%
$518,8370.0%$2.49
0
2025-Q3
Unchanged
213,513
0.0%
$809,2140.0%$3.73
0
2025-Q2
Decreased
213,513
-75.4%
$529,5120.0%$2.35
0
2025-Q1
Decreased
867,191
-1.8%
$1.3M0.0%$1.61
0
2024-Q4
Increased
883,441
+9.2%
$1.9M0.0%$2.15
28
2024-Q3
Increased
809,196
+17.2%
$3.5M0.0%$4.23
31

Other major holders of BDTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used